Electrophysiologic Characterization of Developing Human Embryonic Stem Cell-Derived Photoreceptor Precursors.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
entrez:
29
9
2020
pubmed:
30
9
2020
medline:
1
4
2021
Statut:
ppublish
Résumé
Photoreceptor precursor cells (PRPs) differentiated from human embryonic stem cells can serve as a source for cell replacement therapy aimed at vision restoration in patients suffering from degenerative diseases of the outer retina, such as retinitis pigmentosa and AMD. In this work, we studied the electrophysiologic maturation of PRPs throughout the differentiation process. Human embryonic stem cells were differentiated into PRPs and whole-cell recordings were performed for electrophysiologic characterization at days 0, 30, 60, and 90 along with quantitative PCR analysis to characterize the expression level of various ion channels, which shape the electrophysiologic response. Finally, to characterize the electrically induced calcium currents, we employed calcium imaging (rhod4) to visualize intracellular calcium dynamics in response to electrical activation. Our results revealed an early and steady presence (approximately 100% of responsive cells) of the delayed potassium rectifier current. In contrast, the percentage of cells exhibiting voltage-gated sodium currents increased with maturation (from 0% to almost 90% of responsive cells at 90 days). Moreover, calcium imaging revealed the presence of voltage-gated calcium currents, which play a major role in vision formation. These results were further supported by quantitative PCR analysis, which revealed a significant and continuous (3- to 50-fold) increase in the expression of various voltage-gated channels concomitantly with the increase in the expression of the photoreceptor marker CRX. These results can shed light on the electrophysiologic maturation of neurons in general and PRP in particular and can form the basis for devising and optimizing cell replacement-based vision restoration strategies.
Identifiants
pubmed: 32991686
pii: 2770845
doi: 10.1167/iovs.61.11.44
pmc: PMC7533729
doi:
Substances chimiques
Potassium Channels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
44Références
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7553-8
pubmed: 15897456
Nat Protoc. 2011 Dec 15;7(1):69-79
pubmed: 22179593
Nature. 2012 May 3;485(7396):99-103
pubmed: 22522934
Stem Cells. 2012 Jul;30(7):1424-35
pubmed: 22570183
J Biol Chem. 2015 Jan 16;290(3):1505-21
pubmed: 25468907
Stem Cells. 2013 Jun;31(6):1149-59
pubmed: 23495178
Photochem Photobiol. 2007 Mar-Apr;83(2):317-22
pubmed: 16995772
J Neurosci. 2007 Mar 21;27(12):3069-77
pubmed: 17376968
Nat Neurosci. 2001 Nov;4 Suppl:1207-14
pubmed: 11687831
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5443-8
pubmed: 21402906
J Neurosci. 1999 Mar 1;19(5):1728-35
pubmed: 10024359
Eye (Lond). 2015 May;29(5):681-90
pubmed: 25771816
Neuron. 2001 May;30(2):451-8
pubmed: 11395006
Arch Ophthalmol. 2003 Jul;121(7):1028-33
pubmed: 12860808
Mol Cell Neurosci. 2011 May;47(1):36-44
pubmed: 21362477
Invest Ophthalmol Vis Sci. 1999 Jan;40(1):143-8
pubmed: 9888437
Front Neural Circuits. 2018 Mar 06;12:17
pubmed: 29559897
Brain Res. 2002 Jul 5;943(1):48-55
pubmed: 12088838
J Neurosci. 2001 Jul 1;21(13):4543-50
pubmed: 11425883
Prog Retin Eye Res. 1998 Apr;17(2):207-30
pubmed: 9695793
Invest Ophthalmol Vis Sci. 2005 Jan;46(1):390-7
pubmed: 15623800
J Comp Neurol. 2008 Jun 20;508(6):940-51
pubmed: 18399542
Ophthalmology. 2017 Dec;124(12):1753-1763
pubmed: 28712657
Nat Commun. 2011 Nov 08;2:532
pubmed: 22068599
Exp Eye Res. 2013 Nov;116:279-90
pubmed: 24060343
PLoS One. 2013 May 13;8(5):e63853
pubmed: 23675510
Neurotoxicology. 2005 Oct;26(5):743-52
pubmed: 15950285
Exp Eye Res. 2019 Mar;180:29-38
pubmed: 30447199
Arch Ophthalmol. 1997 Apr;115(4):511-5
pubmed: 9109761
J Biol Chem. 2016 Jul 22;291(30):15663-73
pubmed: 27226626
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7986-91
pubmed: 12060745
J Neurophysiol. 2007 Sep;98(3):1213-22
pubmed: 17652418
Nat Biotechnol. 2013 Aug;31(8):741-7
pubmed: 23873086
J Neurosci. 2018 Jul 4;38(27):6145-6160
pubmed: 29875267
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11331-6
pubmed: 16076961
PLoS One. 2014 Jul 29;9(7):e103418
pubmed: 25072157
Stem Cell Reports. 2018 Apr 10;10(4):1267-1281
pubmed: 29526738
Cell Stem Cell. 2013 May 2;12(5):573-86
pubmed: 23642366
Nat Commun. 2016 Oct 04;7:13028
pubmed: 27701381
PLoS One. 2016 Jan 25;11(1):e0147728
pubmed: 26807953
Stem Cells. 2016 Feb;34(2):311-21
pubmed: 26608863
Eur J Hum Genet. 2002 Aug;10(8):449-56
pubmed: 12111638
Prog Retin Eye Res. 2019 Mar;69:1-37
pubmed: 30445193
Biol Reprod. 2003 Dec;69(6):2007-14
pubmed: 12930726
Retina. 2010 Jan;30(1):51-62
pubmed: 19952985
Mol Vis. 2007 Nov 27;13:2163-82
pubmed: 18079688
Am J Hum Genet. 2006 Sep;79(3):574-9
pubmed: 16909397
Nat Commun. 2016 Oct 04;7:13029
pubmed: 27701378
Neuron. 2001 May;30(2):303-5
pubmed: 11394991
Nat Commun. 2014 Jun 10;5:4047
pubmed: 24915161
Stem Cells. 2011 Aug;29(8):1206-18
pubmed: 21678528
Neuron. 1997 Jun;18(6):959-68
pubmed: 9208863
Curr Top Membr. 2013;72:231-65
pubmed: 24210432
PLoS One. 2010 Jan 20;5(1):e8763
pubmed: 20098701
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):5144-50
pubmed: 18599568
Front Mol Neurosci. 2017 Dec 05;10:394
pubmed: 29259539
Curr Biol. 2014 Oct 6;24(19):2301-6
pubmed: 25220059
Can J Ophthalmol. 2000 Jun;35(4):204-13
pubmed: 10900517
Channels (Austin). 2013 Nov-Dec;7(6):514-23
pubmed: 24064553
Neuron. 2015 Sep 23;87(6):1248-1260
pubmed: 26402607
Nat Neurosci. 2004 Oct;7(10):1079-87
pubmed: 15452577
Harefuah. 1975 Nov 2;89(9):395-6
pubmed: 1205398
Nat Biotechnol. 2008 Feb;26(2):215-24
pubmed: 18246062
Am J Ophthalmol. 2016 Jan;161:29-35.e1
pubmed: 26410132
Stem Cells. 2018 Oct;36(10):1535-1551
pubmed: 30004612
J Neurosci. 2009 May 6;29(18):5841-53
pubmed: 19420251